Goki Ishikawa
President bij Fujirebio Holdings, Inc.
Profiel
Goki Ishikawa is currently the President & Representative Director at Fujirebio Holdings, Inc. He previously held the position of President & Representative Director at Fujirebio, Inc. He completed his undergraduate degree at the University of Tokyo in 1999.
Actieve functies van Goki Ishikawa
| Bedrijven | Functie | Begin |
|---|---|---|
Fujirebio Holdings, Inc.
 Fujirebio Holdings, Inc. BiotechnologyHealth Technology Founded in 2017, Fujirebio Holdings, Inc. is a Japanese company that develops diagnostic products for neurodegenerative diseases. Part of H.U. Group Holdings, Inc., the company is based in Tokyo, Japan. | President | 01-06-2020 |
Eerdere bekende functies van Goki Ishikawa
| Bedrijven | Functie | Einde |
|---|---|---|
Fujirebio, Inc.
 Fujirebio, Inc. Medical SpecialtiesHealth Technology Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan. | President | - |
Opleiding van Goki Ishikawa
| University of Tokyo | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Fujirebio, Inc.
Fujirebio, Inc. Medical SpecialtiesHealth Technology Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan. | Health Technology |
Fujirebio Holdings, Inc.
Fujirebio Holdings, Inc. BiotechnologyHealth Technology Founded in 2017, Fujirebio Holdings, Inc. is a Japanese company that develops diagnostic products for neurodegenerative diseases. Part of H.U. Group Holdings, Inc., the company is based in Tokyo, Japan. | Health Technology |
